SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-013558
Filing Date
2023-04-27
Accepted
2023-04-27 16:00:36
Documents
15

Document Format Files

Seq Description Document Type Size
1 DEF 14A crdf-20230427.htm   iXBRL DEF 14A 659212
6 crdf-20230427_g1.jpg GRAPHIC 54014
  Complete submission text file 0001628280-23-013558.txt   1372376

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230427.xsd EX-101.SCH 4690
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20230427_def.xml EX-101.DEF 6123
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230427_lab.xml EX-101.LAB 10381
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230427_pre.xml EX-101.PRE 5758
9 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230427_htm.xml XML 134449
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35558 | Film No.: 23856570
SIC: 2836 Biological Products, (No Diagnostic Substances)